Impact of the pharmacist on a multidisciplinary team in an antimicrobial stewardship program: a quasi-experimental study

Lucas Magedanz1, Erci Maria Silliprandi1, Rodrigo Pires dos Santos2,1
1Hospital Infection Control Service, Instituto de Cardiologia Fundação, Universitária de Cardiologia de Porto Alegre, Porto Alegre, Brazil
2Hospital Infection Control Committee, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil

Tóm tắt

Từ khóa


Tài liệu tham khảo

Kollef MH. Broad-spectrum antimicrobials and the treatment of serious bacterial infections: getting it right up front. Clin Infect Dis. 2008;47(Suppl 1):S3–13.

Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, Infectious Diseases Society of America; Society for Healthcare Epidemiology of America, et al. Infectious diseases society of America and the society for healthcare epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159–77.

Natsch S, Hekster YA, de Jong R, Heerdink ER, Herings RM, van der Meer JW. Application of the ATC/DDD methodology to monitor antibiotic drug use. Eur J Clin Microbiol Infect Dis. 1998;17:20–4.

Hindler JF, Stelling J. Analysis and presentation of cumulative antibiograms: a new consensus guideline from the Clinical and Laboratory Standards Institute. Clin Infect Dis. 2007;44:867–73.

Carling P, Fung T, Killion A, Terrin N, Barza M. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol. 2003;24:699–706.

Solomon DH, Van Houten L, Glynn RJ, Baden L, Curtis K, Schrager H, et al. Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Arch Intern Med. 2001;161:1897–902.

Pakyz AL, Oinonen M, Polk RE. Relationship of Carbapenem restriction in 22 University teaching hospitals to Carbapenem use and Carbapenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2009;53:1983–6.

Burke JP. Antibiotic resistance—squeezing the balloon? JAMA. 1998;280:1270–1.

Paterson DL. “Collateral damage” from cephalosporin or fluoroquinolone antibiotic therapy. Clin Infect Dis. 2004;38(Suppl 4):S341–5.

MacKenzie FM, Gould IM, Bruce J, Mollison J, Monnet DL, Krcmery V, et al. The role of microbiology and pharmacy departments in the stewardship of antibiotic prescribing in European hospitals. J Hosp Infect. 2007;65(Suppl 2):73–81.

Gross R, Morgan AS, Kinky DE, Weiner M, Gibson GA, Fishman NO. Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. Clin Infect Dis. 2001;33:289–95.